NCT02292277View on ClinicalTrials.gov

Ticagrelor Pharmacokinetics in NSTEMI

CompletedOBSERVATIONAL

Enrollment

63

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

January 31, 2016

Conditions

Myocardial Infarction

Interventions

DRUG

Ticagrelor

Oral loading dose of 180 mg ticagrelor.

Trial Locations (1)

118 83

Södersjukhuset, Stockholm

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Karolinska University Hospital

OTHER